SLC7A11 Human (+)-dexrazoxane multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Dexrazoxane inhibits the reaction [Cyclophosphamide results in decreased expression of SLC7A11 protein] CTD PMID:37690746 SLC7A11 Human (+)-schisandrin B multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC7A11 mRNA] CTD PMID:31150632 SLC7A11 Human (-)-alpha-phellandrene decreases expression EXP 6480464 alpha phellandrene results in decreased expression of SLC7A11 mRNA CTD PMID:25075043 SLC7A11 Human (-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of SLC7A11 mRNA CTD PMID:23649840 SLC7A11 Human (1->4)-beta-D-glucan multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC7A11 mRNA CTD PMID:36331819 SLC7A11 Human (E)-thiamethoxam increases expression ISO Slc7a11 (Mus musculus) 6480464 Thiamethoxam results in increased expression of SLC7A11 mRNA CTD PMID:33533595 SLC7A11 Human (R)-lipoic acid multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 Thioctic Acid inhibits the reaction [methylmercuric chloride results in decreased expression of SLC7A11 protein] and Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of SLC7A11 mRNA] CTD PMID:32061141 SLC7A11 Human (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 mRNA and [alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 protein CTD PMID:24530478 SLC7A11 Human (S)-AMPA multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Propofol results in decreased expression of SLC7A11 protein] CTD PMID:28663055 SLC7A11 Human (S)-ropivacaine decreases expression EXP 6480464 Ropivacaine results in decreased expression of SLC7A11 protein CTD PMID:36124980 SLC7A11 Human 1,3-benzothiazole-2-thiol increases expression EXP 6480464 captax results in increased expression of SLC7A11 mRNA CTD PMID:24211530 SLC7A11 Human 1,3-dichloropropan-2-ol decreases expression EXP 6480464 1 and 3-dichloro-2-propanol results in decreased expression of SLC7A11 protein CTD PMID:35870111 SLC7A11 Human 1,3-dichloropropan-2-ol decreases expression ISO Slc7a11 (Mus musculus) 6480464 1 and 3-dichloro-2-propanol results in decreased expression of SLC7A11 protein CTD PMID:35870111 SLC7A11 Human 1,3-dichloropropan-2-ol multiple interactions EXP 6480464 [Thiazoles binds to indoline] promotes the reaction [1 more ... CTD PMID:35870111 SLC7A11 Human 1-nitropyrene decreases expression ISO Slc7a11 (Mus musculus) 6480464 1-nitropyrene results in decreased expression of SLC7A11 protein CTD PMID:37993079 SLC7A11 Human 1-nitropyrene decreases expression EXP 6480464 1-nitropyrene results in decreased expression of SLC7A11 protein CTD PMID:37993079 SLC7A11 Human 1-nitropyrene multiple interactions EXP 6480464 CYP1B1 protein promotes the reaction [1-nitropyrene results in decreased expression of SLC7A11 protein] and ferrostatin-1 inhibits the reaction [1-nitropyrene results in decreased expression of SLC7A11 protein] CTD PMID:37993079 SLC7A11 Human 1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester increases expression EXP 6480464 carbetapentane results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC7A11 mRNA CTD PMID:20170705 SLC7A11 Human 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of SLC7A11 mRNA CTD PMID:22574217 SLC7A11 Human 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC7A11 mRNA CTD PMID:30165855 SLC7A11 Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC7A11 mRNA CTD PMID:15159206 more ... SLC7A11 Human 17beta-estradiol multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SLC7A11 mRNA CTD PMID:26496021 SLC7A11 Human 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of SLC7A11 mRNA CTD PMID:16474171 and PMID:19167446 SLC7A11 Human 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:38568856 SLC7A11 Human 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19095052 more ... SLC7A11 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc7a11 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A11 mRNA CTD PMID:22298810 and PMID:32109520 SLC7A11 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC7A11 mRNA CTD PMID:33387578 SLC7A11 Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC7A11 mRNA CTD PMID:26159488 SLC7A11 Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC7A11 mRNA CTD PMID:26159488 SLC7A11 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc7a11 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A11 mRNA CTD PMID:21570461 SLC7A11 Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC7A11 mRNA CTD PMID:21632981 SLC7A11 Human 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A11 mRNA CTD PMID:20106945 and PMID:22298810 SLC7A11 Human 2,3,7,8-Tetrachlorodibenzofuran decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 SLC7A11 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:26705709 SLC7A11 Human 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Slc7a11 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 SLC7A11 Human 2-(chloromethyl)pyridine increases expression EXP 6480464 2-chloromethylpyridine results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human 2-amino-4-methylphenol affects response to substance EXP 6480464 SLC7A11 gene SNP affects the susceptibility to 2-amino-4-methylphenol CTD PMID:25622337 SLC7A11 Human 2-butoxyethanol increases expression ISO Slc7a11 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of SLC7A11 mRNA CTD PMID:19812364 SLC7A11 Human 2-deoxy-D-glucose decreases expression EXP 6480464 Deoxyglucose results in decreased expression of SLC7A11 protein CTD PMID:37927237 SLC7A11 Human 2-tert-butylhydroquinone increases expression ISO Slc7a11 (Mus musculus) 6480464 2-tert-butylhydroquinone results in increased expression of SLC7A11 mRNA CTD PMID:19183254 SLC7A11 Human 2-tert-butylhydroquinone increases expression EXP 6480464 2-tert-butylhydroquinone results in increased expression of SLC7A11 mRNA and 2-tert-butylhydroquinone results in increased expression of SLC7A11 protein CTD PMID:37716422 SLC7A11 Human 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of SLC7A11 mRNA] and 2-tert-butylhydroquinone inhibits the reaction [Matrines results in decreased expression of SLC7A11 protein] CTD PMID:37716422 SLC7A11 Human 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:19692669 and PMID:23146750 SLC7A11 Human 3,3',4,4'-tetrachlorobiphenyl affects expression EXP 6480464 3 more ... CTD PMID:20638727 SLC7A11 Human 3,3',5,5'-tetrabromobisphenol A increases expression ISO Slc7a11 (Mus musculus) 6480464 tetrabromobisphenol A results in increased expression of SLC7A11 mRNA CTD PMID:25172293 SLC7A11 Human 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of SLC7A11 mRNA CTD PMID:25424538 and PMID:33476716 SLC7A11 Human 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human 3-(indol-3-yl)pyruvic acid multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[indol-3-yl pyruvic acid co-treated with erastin] results in increased expression of SLC7A11 protein] more ... CTD PMID:38641223 SLC7A11 Human 3-chloropropane-1,2-diol increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 alpha-Chlorohydrin results in increased expression of SLC7A11 mRNA CTD PMID:28522335 SLC7A11 Human 3-methyl-3H-imidazo[4,5-f]quinolin-2-amine increases expression EXP 6480464 2-amino-3-methylimidazo(4 and 5-f)quinoline results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human 3-methyladenine multiple interactions ISO Slc7a11 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein] CTD PMID:38220133 SLC7A11 Human 3-phenylprop-2-enal increases expression EXP 6480464 cinnamaldehyde results in increased expression of SLC7A11 mRNA CTD PMID:17178418 more ... SLC7A11 Human 4,4'-diaminodiphenylmethane increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of SLC7A11 mRNA CTD PMID:30723492 SLC7A11 Human 4,4'-methylene-bis-(2-chloroaniline) increases expression EXP 6480464 Methylenebis(chloroaniline) results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human 4,4'-sulfonyldiphenol increases methylation EXP 6480464 bisphenol S results in increased methylation of SLC7A11 gene CTD PMID:31601247 SLC7A11 Human 4-aminosalicylic acid increases expression EXP 6480464 Aminosalicylic Acid results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human 4-Carboxyphenylglycine decreases activity EXP 6480464 4-carboxyphenylglycine results in decreased activity of SLC7A11 protein CTD PMID:20007406 SLC7A11 Human 4-hydroxy-TEMPO multiple interactions EXP 6480464 NFE2L2 protein affects the reaction [tempol inhibits the reaction [lipopolysaccharide more ... CTD PMID:38454815 SLC7A11 Human 4-hydroxy-TEMPO multiple interactions ISO Slc7a11 (Mus musculus) 6480464 tempol inhibits the reaction [lipopolysaccharide and E coli O55-B5 results in decreased expression of SLC7A11 protein] CTD PMID:38454815 SLC7A11 Human 4-hydroxynon-2-enal multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [APC protein mutant form results in increased expression of SLC7A11 mRNA] which affects the metabolism of 4-hydroxy-2-nonenal CTD PMID:21967605 SLC7A11 Human 4-hydroxynon-2-enal multiple interactions EXP 6480464 [[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of 4-hydroxy-2-nonenal CTD PMID:35234341 SLC7A11 Human 4-nitro-1,2-phenylenediamine increases expression EXP 6480464 1 and 2-diamino-4-nitrobenzene results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Particulate Matter results in decreased expression of SLC7A11 protein] CTD PMID:36700298 SLC7A11 Human 6-propyl-2-thiouracil increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Propylthiouracil results in increased expression of SLC7A11 mRNA CTD PMID:24780913 SLC7A11 Human 6-propyl-2-thiouracil decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of SLC7A11 mRNA CTD PMID:25825206 SLC7A11 Human 6alpha-methylprednisolone decreases expression EXP 6480464 Methylprednisolone results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 SLC7A11 Human 7beta-aminocephalosporanic acid increases expression EXP 6480464 7-aminocephalosporanic acid results in increased expression of SLC7A11 mRNA CTD PMID:24211530 SLC7A11 Human 8-Br-cAMP decreases expression EXP 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SLC7A11 mRNA CTD PMID:22079614 SLC7A11 Human [6]-Shogaol decreases expression EXP 6480464 shogaol results in decreased expression of SLC7A11 mRNA and shogaol results in decreased expression of SLC7A11 protein CTD PMID:36341865 SLC7A11 Human acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human acrolein increases expression EXP 6480464 Acrolein results in increased expression of SLC7A11 mRNA CTD PMID:24211530 SLC7A11 Human acrolein increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Acrolein results in increased expression of SLC7A11 mRNA CTD PMID:38090360 SLC7A11 Human acrolein multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC7A11 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC7A11 mRNA CTD PMID:32699268 SLC7A11 Human acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC7A11 mRNA CTD PMID:23287710 and PMID:32763439 SLC7A11 Human acrylamide decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Acrylamide results in decreased expression of SLC7A11 mRNA CTD PMID:36154307 SLC7A11 Human acrylamide increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Acrylamide results in increased expression of SLC7A11 mRNA CTD PMID:28959563 SLC7A11 Human actinomycin D decreases expression EXP 6480464 Dactinomycin results in decreased expression of SLC7A11 protein CTD PMID:31226288 SLC7A11 Human acyclovir increases expression EXP 6480464 Acyclovir results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human aflatoxin B1 affects expression EXP 6480464 Aflatoxin B1 affects the expression of SLC7A11 protein CTD PMID:20106945 SLC7A11 Human aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SLC7A11 mRNA CTD PMID:22100608 more ... SLC7A11 Human aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of SLC7A11 gene CTD PMID:27153756 SLC7A11 Human aflatoxin B1 increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Aflatoxin B1 results in increased expression of SLC7A11 mRNA CTD PMID:23630614 and PMID:25378103 SLC7A11 Human aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of SLC7A11 mRNA CTD PMID:21632981 SLC7A11 Human aflatoxin B1 decreases expression ISO Slc7a11 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of SLC7A11 mRNA CTD PMID:19770486 SLC7A11 Human aldehydo-D-glucose multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:36806343 SLC7A11 Human all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of SLC7A11 mRNA CTD PMID:21934132 and PMID:23724009 SLC7A11 Human alpha-phellandrene decreases expression EXP 6480464 alpha phellandrene results in decreased expression of SLC7A11 mRNA CTD PMID:25075043 SLC7A11 Human alpha-pinene multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC7A11 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC7A11 mRNA CTD PMID:32699268 SLC7A11 Human alpha-Zearalanol increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Zeranol results in increased expression of SLC7A11 mRNA CTD PMID:35163327 SLC7A11 Human alpidem increases expression EXP 6480464 alpidem results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human amikacin decreases expression EXP 6480464 Amikacin results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of SLC7A11 mRNA CTD PMID:36586010 SLC7A11 Human ammonium hexachloroplatinate increases expression EXP 6480464 ammonium hexachloroplatinate results in increased expression of SLC7A11 mRNA CTD PMID:24211530 SLC7A11 Human amphetamine increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Amphetamine results in increased expression of SLC7A11 mRNA CTD PMID:30779732 SLC7A11 Human ampicillin decreases expression EXP 6480464 Ampicillin results in decreased expression of SLC7A11 mRNA CTD PMID:21632981 and PMID:26198647 SLC7A11 Human andrographolide increases expression ISO Slc7a11 (Mus musculus) 6480464 andrographolide results in increased expression of SLC7A11 mRNA CTD PMID:19737545 SLC7A11 Human apigenin multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC7A11 mRNA] CTD PMID:35500696 SLC7A11 Human arachidonic acid increases expression EXP 6480464 Arachidonic Acid results in increased expression of SLC7A11 mRNA CTD PMID:16704987 SLC7A11 Human aristolochic acid A decreases expression EXP 6480464 aristolochic acid I results in decreased expression of SLC7A11 mRNA CTD PMID:33212167 SLC7A11 Human arsane affects methylation EXP 6480464 Arsenic affects the methylation of SLC7A11 gene CTD PMID:25304211 and PMID:32603190 SLC7A11 Human arsane decreases expression ISO Slc7a11 (Mus musculus) 6480464 Arsenic results in decreased expression of SLC7A11 protein CTD PMID:37482551 SLC7A11 Human arsane multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of SLC7A11 protein CTD PMID:37482551 SLC7A11 Human arsane decreases expression EXP 6480464 Arsenic results in decreased expression of SLC7A11 mRNA CTD PMID:38036231 SLC7A11 Human arsane increases expression EXP 6480464 Arsenic results in increased expression of SLC7A11 mRNA CTD PMID:36720308 SLC7A11 Human arsenic atom affects methylation EXP 6480464 Arsenic affects the methylation of SLC7A11 gene CTD PMID:25304211 and PMID:32603190 SLC7A11 Human arsenic atom decreases expression ISO Slc7a11 (Mus musculus) 6480464 Arsenic results in decreased expression of SLC7A11 protein CTD PMID:37482551 SLC7A11 Human arsenic atom multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Arsenic co-treated with Fluorides] results in decreased expression of SLC7A11 protein CTD PMID:37482551 SLC7A11 Human arsenic atom decreases expression EXP 6480464 Arsenic results in decreased expression of SLC7A11 mRNA CTD PMID:38036231 SLC7A11 Human arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of SLC7A11 mRNA CTD PMID:36720308 SLC7A11 Human arsenite(3-) multiple interactions EXP 6480464 arsenite inhibits the reaction [G3BP1 protein binds to SLC7A11 mRNA] CTD PMID:32406909 SLC7A11 Human arsenous acid decreases response to substance EXP 6480464 SLC7A11 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 SLC7A11 Human arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of SLC7A11 mRNA CTD PMID:19128835 more ... SLC7A11 Human atrazine affects methylation ISO Slc7a11 (Rattus norvegicus) 6480464 Atrazine affects the methylation of SLC7A11 gene CTD PMID:28931070 SLC7A11 Human atrazine increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Atrazine results in increased expression of SLC7A11 mRNA CTD PMID:36841081 SLC7A11 Human Augmentin increases expression EXP 6480464 Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA CTD PMID:34767876 SLC7A11 Human Azaspiracid increases expression EXP 6480464 azaspiracid results in increased expression of SLC7A11 mRNA CTD PMID:28939011 SLC7A11 Human azathioprine decreases expression EXP 6480464 Azathioprine results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 SLC7A11 Human azathioprine increases expression EXP 6480464 Azathioprine results in increased expression of SLC7A11 mRNA CTD PMID:22623647 and PMID:26198647 SLC7A11 Human baicalein multiple interactions EXP 6480464 baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein] and SIRT1 protein promotes the reaction [baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein]] CTD PMID:37354967 SLC7A11 Human belinostat decreases expression EXP 6480464 belinostat results in decreased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human benzalkonium chloride increases expression EXP 6480464 Benzalkonium Compounds results in increased expression of SLC7A11 mRNA CTD PMID:30806763 and PMID:37149095 SLC7A11 Human benzene increases expression EXP 6480464 Benzene results in increased expression of SLC7A11 mRNA CTD PMID:20359517 and PMID:21843810 SLC7A11 Human benzene multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Deferoxamine inhibits the reaction [Benzene results in decreased expression of SLC7A11 mRNA] more ... CTD PMID:35661779 SLC7A11 Human benzene decreases expression ISO Slc7a11 (Mus musculus) 6480464 Benzene results in decreased expression of SLC7A11 mRNA and Benzene results in decreased expression of SLC7A11 protein CTD PMID:35661779 SLC7A11 Human benzethonium chloride increases expression EXP 6480464 Benzethonium results in increased expression of SLC7A11 mRNA CTD PMID:37149095 SLC7A11 Human benzidine increases expression EXP 6480464 benzidine results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of SLC7A11 mRNA CTD PMID:20106945 more ... SLC7A11 Human benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of SLC7A11 mRNA CTD PMID:20064835 more ... SLC7A11 Human benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene metabolite results in decreased expression of SLC7A11 mRNA and Benzo(a)pyrene results in decreased expression of SLC7A11 protein CTD PMID:24356939 and PMID:32717239 SLC7A11 Human benzo[a]pyrene increases expression ISO Slc7a11 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC7A11 mRNA CTD PMID:19770486 more ... SLC7A11 Human benzo[a]pyrene diol epoxide I decreases expression EXP 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 SLC7A11 Human benzo[a]pyrene diol epoxide I affects expression EXP 6480464 7 more ... CTD PMID:36450496 SLC7A11 Human benzo[a]pyrene diol epoxide I multiple interactions EXP 6480464 Deferoxamine affects the reaction [7 more ... CTD PMID:36450496 SLC7A11 Human beryllium sulfate multiple interactions EXP 6480464 [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in decreased expression of SLC7A11 mRNA] more ... CTD PMID:36843388 SLC7A11 Human beryllium sulfate decreases expression EXP 6480464 beryllium sulfate results in decreased expression of SLC7A11 mRNA CTD PMID:36843388 SLC7A11 Human beta-lapachone multiple interactions EXP 6480464 ferrostatin-1 inhibits the reaction [beta-lapachone results in decreased expression of SLC7A11 protein] CTD PMID:38218311 SLC7A11 Human beta-lapachone decreases expression EXP 6480464 beta-lapachone results in decreased expression of SLC7A11 protein CTD PMID:38218311 SLC7A11 Human beta-lapachone increases expression EXP 6480464 beta-lapachone results in increased expression of SLC7A11 mRNA CTD PMID:38218311 SLC7A11 Human bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of SLC7A11 mRNA CTD PMID:15638997 SLC7A11 Human bilirubin IXalpha multiple interactions EXP 6480464 [[[Bilirubin results in increased activity of [SLC7A11 protein co-treated with SLC3A2 protein]] which results in increased uptake of Cystine] which results in increased abundance of Glutathione] which results in decreased susceptibility to Hydrogen Peroxide more ... CTD PMID:22216172 SLC7A11 Human bilirubin IXalpha increases expression EXP 6480464 Bilirubin results in increased expression of SLC7A11 mRNA CTD PMID:22216172 SLC7A11 Human biperiden increases expression EXP 6480464 Biperiden results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of SLC7A11 protein CTD PMID:31163220 SLC7A11 Human bis(2-ethylhexyl) phthalate decreases expression ISO Slc7a11 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of SLC7A11 mRNA and Diethylhexyl Phthalate results in decreased expression of SLC7A11 protein CTD PMID:35500696 more ... SLC7A11 Human bis(2-ethylhexyl) phthalate multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Apigenin inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC7A11 mRNA] and ferrostatin-1 inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of SLC7A11 protein] CTD PMID:35500696 and PMID:36438553 SLC7A11 Human bis(2-ethylhexyl) phthalate increases expression ISO Slc7a11 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of SLC7A11 protein CTD PMID:34863575 SLC7A11 Human bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC7A11 mRNA CTD PMID:20170705 and PMID:30903817 SLC7A11 Human bisphenol A decreases expression ISO Slc7a11 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC7A11 protein CTD PMID:38326183 SLC7A11 Human bisphenol A increases expression ISO Slc7a11 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC7A11 mRNA CTD PMID:35479511 SLC7A11 Human bisphenol A decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 bisphenol A analog results in decreased expression of SLC7A11 mRNA more ... CTD PMID:30816183 more ... SLC7A11 Human bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC7A11 mRNA and bisphenol A results in decreased expression of SLC7A11 protein CTD PMID:16474171 more ... SLC7A11 Human bisphenol A affects expression ISO Slc7a11 (Rattus norvegicus) 6480464 bisphenol A affects the expression of SLC7A11 mRNA CTD PMID:25181051 SLC7A11 Human bisphenol A increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 bisphenol A results in increased expression of SLC7A11 mRNA CTD PMID:26982218 SLC7A11 Human bisphenol A multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of SLC7A11 mRNA CTD PMID:26496021 SLC7A11 Human bisphenol A increases expression EXP 6480464 bisphenol A analog results in increased expression of SLC7A11 mRNA and bisphenol A results in increased expression of SLC7A11 mRNA CTD PMID:29275510 and PMID:32387340 SLC7A11 Human Bisphenol B increases expression EXP 6480464 bisphenol B results in increased expression of SLC7A11 mRNA CTD PMID:32387340 SLC7A11 Human bromfenac decreases expression EXP 6480464 bromfenac results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human bromobenzene increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 bromobenzene results in increased expression of SLC7A11 mRNA CTD PMID:32479839 SLC7A11 Human busulfan decreases expression ISO Slc7a11 (Mus musculus) 6480464 Busulfan results in decreased expression of SLC7A11 mRNA and Busulfan results in decreased expression of SLC7A11 protein CTD PMID:38220133 SLC7A11 Human busulfan multiple interactions ISO Slc7a11 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein] more ... CTD PMID:38220133 SLC7A11 Human buta-1,3-diene increases expression ISO Slc7a11 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of SLC7A11 mRNA CTD PMID:29038090 SLC7A11 Human butanal decreases expression EXP 6480464 butyraldehyde results in decreased expression of SLC7A11 mRNA CTD PMID:26079696 SLC7A11 Human butylated hydroxyanisole decreases expression ISO Slc7a11 (Mus musculus) 6480464 Butylated Hydroxyanisole results in decreased expression of SLC7A11 protein CTD PMID:38657941 SLC7A11 Human butylated hydroxyanisole decreases expression EXP 6480464 Butylated Hydroxyanisole results in decreased expression of SLC7A11 protein CTD PMID:38657941 SLC7A11 Human C.I. Natural Red 20 decreases expression ISO Slc7a11 (Mus musculus) 6480464 shikonin results in decreased expression of SLC7A11 protein CTD PMID:37268198 SLC7A11 Human C.I. Natural Red 20 decreases expression EXP 6480464 shikonin results in decreased expression of SLC7A11 protein CTD PMID:37268198 SLC7A11 Human C.I. Natural Red 20 multiple interactions EXP 6480464 ATF3 protein promotes the reaction [shikonin results in decreased expression of SLC7A11 protein] CTD PMID:37268198 SLC7A11 Human cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of SLC7A11 mRNA CTD PMID:24376830 SLC7A11 Human cadmium atom multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC7A11 mRNA CTD PMID:29741670 and PMID:35301059 SLC7A11 Human cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of SLC7A11 mRNA CTD PMID:21172416 and PMID:23369406 SLC7A11 Human cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SLC7A11 mRNA CTD PMID:25596134 SLC7A11 Human cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of SLC7A11 mRNA CTD PMID:38382870 SLC7A11 Human cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SLC7A11 mRNA CTD PMID:29741670 and PMID:35301059 SLC7A11 Human cannabidiol increases expression ISO Slc7a11 (Mus musculus) 6480464 Cannabidiol results in increased expression of SLC7A11 mRNA CTD PMID:21542829 and PMID:30742662 SLC7A11 Human cannabidiol increases expression EXP 6480464 Cannabidiol results in increased expression of SLC7A11 mRNA CTD PMID:31518892 SLC7A11 Human cannabidiol decreases expression EXP 6480464 Cannabidiol results in decreased expression of SLC7A11 protein CTD PMID:38583854 SLC7A11 Human cannabidiol multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [lipopolysaccharide and E coli O55-B5 co-treated with Cannabidiol] results in increased expression of SLC7A11 mRNA CTD PMID:30742662 SLC7A11 Human captan increases expression ISO Slc7a11 (Mus musculus) 6480464 Captan results in increased expression of SLC7A11 mRNA CTD PMID:31558096 SLC7A11 Human carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of SLC7A11 mRNA CTD PMID:25979313 SLC7A11 Human carbon nanotube increases expression ISO Slc7a11 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of SLC7A11 mRNA CTD PMID:25554681 SLC7A11 Human ceftriaxone multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] CTD PMID:19717140 SLC7A11 Human celastrol decreases response to substance EXP 6480464 SLC7A11 protein results in decreased susceptibility to celastrol CTD PMID:20007406 SLC7A11 Human celastrol increases expression EXP 6480464 celastrol results in increased expression of SLC7A11 mRNA CTD PMID:17010675 SLC7A11 Human celecoxib increases expression EXP 6480464 Celecoxib results in increased expression of SLC7A11 mRNA CTD PMID:33785417 SLC7A11 Human cetylpyridinium increases expression EXP 6480464 Cetylpyridinium results in increased expression of SLC7A11 mRNA CTD PMID:37149095 SLC7A11 Human chlordecone increases expression ISO Slc7a11 (Mus musculus) 6480464 Chlordecone results in increased expression of SLC7A11 mRNA CTD PMID:33711761 SLC7A11 Human chloroacetaldehyde increases expression EXP 6480464 chloroacetaldehyde results in increased expression of SLC7A11 mRNA CTD PMID:25596134 SLC7A11 Human chloropicrin increases expression EXP 6480464 chloropicrin results in increased expression of SLC7A11 mRNA CTD PMID:24211530 SLC7A11 Human chloroprene increases expression ISO Slc7a11 (Mus musculus) 6480464 Chloroprene results in increased expression of SLC7A11 mRNA CTD PMID:23125180 SLC7A11 Human chloroquine multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Chloroquine inhibits the reaction [Cisplatin results in decreased expression of SLC7A11 protein] CTD PMID:34302894 SLC7A11 Human chloroquine multiple interactions EXP 6480464 Chloroquine inhibits the reaction [Particulate Matter results in decreased expression of SLC7A11 protein] CTD PMID:36700298 SLC7A11 Human chlorpyrifos decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Chlorpyrifos results in decreased expression of SLC7A11 mRNA CTD PMID:20600679 SLC7A11 Human chlorpyrifos decreases expression ISO Slc7a11 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of SLC7A11 mRNA CTD PMID:37019170 SLC7A11 Human chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of SLC7A11 mRNA CTD PMID:25424538 SLC7A11 Human chlorpyrifos multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Chlorpyrifos co-treated with NGF protein] results in decreased expression of SLC7A11 mRNA CTD PMID:20600679 SLC7A11 Human choline multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC7A11 mRNA CTD PMID:20938992 SLC7A11 Human cisplatin affects response to substance EXP 6480464 SLC7A11 protein affects the susceptibility to Cisplatin CTD PMID:16217747 and PMID:31226288 SLC7A11 Human cisplatin multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Chloroquine inhibits the reaction [Cisplatin results in decreased expression of SLC7A11 protein] more ... CTD PMID:34302894 and PMID:34785303 SLC7A11 Human cisplatin decreases expression ISO Slc7a11 (Mus musculus) 6480464 Cisplatin results in decreased expression of SLC7A11 protein CTD PMID:34302894 and PMID:34785303 SLC7A11 Human cisplatin decreases response to substance EXP 6480464 SLC7A11 protein results in decreased susceptibility to Cisplatin CTD PMID:37987512 SLC7A11 Human cisplatin increases sumoylation EXP 6480464 Cisplatin results in increased sumoylation of SLC7A11 protein CTD PMID:37987512 SLC7A11 Human cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of SLC7A11 mRNA and Cisplatin results in decreased expression of SLC7A11 protein CTD PMID:26198647 more ... SLC7A11 Human cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SLC7A11 mRNA CTD PMID:27594783 SLC7A11 Human cisplatin multiple interactions EXP 6480464 [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of SLC7A11 mRNA more ... CTD PMID:30871063 more ... SLC7A11 Human cisplatin increases expression ISO Slc7a11 (Mus musculus) 6480464 Cisplatin results in increased expression of SLC7A11 mRNA CTD PMID:21151649 SLC7A11 Human clavulanic acid increases expression EXP 6480464 Clavulanic Acid results in increased expression of SLC7A11 mRNA CTD PMID:32816093 and PMID:34767876 SLC7A11 Human clavulanic acid decreases expression EXP 6480464 Clavulanic Acid results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human cobalt dichloride increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 cobaltous chloride results in increased expression of SLC7A11 mRNA CTD PMID:24386269 SLC7A11 Human cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of SLC7A11 mRNA CTD PMID:22941251 and PMID:24356939 SLC7A11 Human cocaine multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] and Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] CTD PMID:19717140 SLC7A11 Human cocaine decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Cocaine results in decreased expression of SLC7A11 protein CTD PMID:19717140 SLC7A11 Human copper atom increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of SLC7A11 mRNA CTD PMID:26033743 SLC7A11 Human copper atom multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of SLC7A11 mRNA and [NSC 689534 binds to Copper] which results in increased expression of SLC7A11 mRNA CTD PMID:20971185 and PMID:30911355 SLC7A11 Human copper(0) increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Copper deficiency results in increased expression of SLC7A11 mRNA CTD PMID:26033743 SLC7A11 Human copper(0) multiple interactions EXP 6480464 [Chelating Agents binds to Copper] which results in increased expression of SLC7A11 mRNA and [NSC 689534 binds to Copper] which results in increased expression of SLC7A11 mRNA CTD PMID:20971185 and PMID:30911355 SLC7A11 Human copper(II) chloride increases expression EXP 6480464 cupric chloride results in increased expression of SLC7A11 mRNA CTD PMID:38568856 SLC7A11 Human copper(II) sulfate decreases expression EXP 6480464 Copper Sulfate results in decreased expression of SLC7A11 mRNA CTD PMID:20599845 SLC7A11 Human copper(II) sulfate increases expression EXP 6480464 Copper Sulfate results in increased expression of SLC7A11 mRNA CTD PMID:19549813 and PMID:20599845 SLC7A11 Human corosolic acid increases expression EXP 6480464 corosolic acid results in increased expression of SLC7A11 mRNA and corosolic acid results in increased expression of SLC7A11 protein CTD PMID:37939859 SLC7A11 Human coumaphos increases expression EXP 6480464 Coumaphos results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human coumestrol decreases expression EXP 6480464 Coumestrol results in decreased expression of SLC7A11 mRNA CTD PMID:19167446 SLC7A11 Human coumestrol multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA CTD PMID:19167446 SLC7A11 Human crocidolite asbestos affects expression EXP 6480464 Asbestos and Crocidolite affects the expression of SLC7A11 mRNA CTD PMID:25757056 SLC7A11 Human Cuprizon increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Cuprizone results in increased expression of SLC7A11 mRNA CTD PMID:26577399 and PMID:27523638 SLC7A11 Human curcumin increases expression EXP 6480464 Curcumin results in increased expression of SLC7A11 mRNA CTD PMID:17999991 SLC7A11 Human curcumin multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 Curcumin inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of SLC7A11 protein] CTD PMID:34787501 SLC7A11 Human curcumin increases expression ISO Slc7a11 (Mus musculus) 6480464 Curcumin results in increased expression of SLC7A11 mRNA CTD PMID:19183254 SLC7A11 Human cyclophosphamide affects expression EXP 6480464 Cyclophosphamide affects the expression of SLC7A11 mRNA CTD PMID:23824090 SLC7A11 Human cyclophosphamide multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Dexrazoxane inhibits the reaction [Cyclophosphamide results in decreased expression of SLC7A11 protein] CTD PMID:37690746 SLC7A11 Human cyclophosphamide decreases expression ISO Slc7a11 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of SLC7A11 protein CTD PMID:37690746 SLC7A11 Human cyclophosphamide decreases expression EXP 6480464 Cyclophosphamide metabolite results in decreased expression of SLC7A11 mRNA CTD PMID:24356939 SLC7A11 Human cyclosporin A increases expression ISO Slc7a11 (Mus musculus) 6480464 Cyclosporine results in increased expression of SLC7A11 mRNA CTD PMID:19770486 SLC7A11 Human cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of SLC7A11 mRNA CTD PMID:19159671 more ... SLC7A11 Human cyclosporin A increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Cyclosporine results in increased expression of SLC7A11 mRNA CTD PMID:25596134 SLC7A11 Human cypermethrin increases expression EXP 6480464 cypermethrin results in increased expression of SLC7A11 mRNA CTD PMID:25424538 SLC7A11 Human D-glucose multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:36806343 SLC7A11 Human DDE decreases expression EXP 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of SLC7A11 mRNA CTD PMID:38568856 SLC7A11 Human DDT increases expression EXP 6480464 DDT results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human deoxynivalenol decreases expression EXP 6480464 deoxynivalenol results in decreased expression of SLC7A11 mRNA CTD PMID:31863870 and PMID:37419272 SLC7A11 Human deoxynivalenol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of SLC7A11 protein] CTD PMID:37419272 SLC7A11 Human deoxynivalenol increases expression ISO Slc7a11 (Mus musculus) 6480464 deoxynivalenol results in increased expression of SLC7A11 protein CTD PMID:38040082 SLC7A11 Human desferrioxamine B decreases expression EXP 6480464 Deferoxamine results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human desferrioxamine B multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Deferoxamine inhibits the reaction [Benzene results in decreased expression of SLC7A11 mRNA] more ... CTD PMID:35661779 and PMID:38220133 SLC7A11 Human desferrioxamine B multiple interactions EXP 6480464 Deferoxamine affects the reaction [7 more ... CTD PMID:36450496 and PMID:36843388 SLC7A11 Human diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of SLC7A11 mRNA CTD PMID:19128835 more ... SLC7A11 Human diarsenic trioxide decreases response to substance EXP 6480464 SLC7A11 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 SLC7A11 Human diazinon increases expression EXP 6480464 Diazinon results in increased expression of SLC7A11 mRNA CTD PMID:24356939 and PMID:26198647 SLC7A11 Human dichloromethane increases expression EXP 6480464 Methylene Chloride results in increased expression of SLC7A11 mRNA CTD PMID:20359517 SLC7A11 Human diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 and PMID:33785417 SLC7A11 Human diclofenac decreases expression ISO Slc7a11 (Mus musculus) 6480464 Diclofenac results in decreased expression of SLC7A11 mRNA CTD PMID:35537566 SLC7A11 Human diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human Didecyldimethylammonium increases expression EXP 6480464 didecyldimethylammonium results in increased expression of SLC7A11 mRNA CTD PMID:32763356 SLC7A11 Human dieldrin multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Dieldrin co-treated with NGF protein] results in increased expression of SLC7A11 mRNA CTD PMID:20600679 SLC7A11 Human diethyl malate increases expression EXP 6480464 diethyl malate results in increased expression of SLC7A11 mRNA CTD PMID:38498338 SLC7A11 Human diethyl maleate multiple interactions ISO Slc7a11 (Mus musculus) 6480464 NFE2L2 gene mutant form inhibits the reaction [diethyl maleate results in increased expression of SLC7A11 mRNA] CTD PMID:12235164 SLC7A11 Human diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of SLC7A11 mRNA CTD PMID:33545341 SLC7A11 Human diethyl maleate increases expression ISO Slc7a11 (Mus musculus) 6480464 diethyl maleate results in increased expression of SLC7A11 mRNA CTD PMID:12235164 SLC7A11 Human diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of SLC7A11 mRNA CTD PMID:15159206 SLC7A11 Human diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human Dihydrocorynantheine multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 hirsutine promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA] CTD PMID:25551766 SLC7A11 Human dimethyl fumarate multiple interactions EXP 6480464 Dimethyl Fumarate inhibits the reaction [1 and 3-dichloro-2-propanol results in decreased expression of SLC7A11 protein] CTD PMID:35870111 SLC7A11 Human dimethyl-(phenylmethyl)-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethyl]ammonium increases expression EXP 6480464 Benzethonium results in increased expression of SLC7A11 mRNA CTD PMID:37149095 SLC7A11 Human dimethylarsinic acid increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Cacodylic Acid results in increased expression of SLC7A11 mRNA CTD PMID:37567419 SLC7A11 Human dimethylarsinous acid increases expression EXP 6480464 dimethylarsinous acid results in increased expression of SLC7A11 mRNA CTD PMID:23487506 SLC7A11 Human dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of SLC7A11 mRNA CTD PMID:25596134 more ... SLC7A11 Human dioxygen multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SLC7A11 mRNA more ... CTD PMID:29045497 more ... SLC7A11 Human diphenhydramine decreases expression EXP 6480464 Diphenhydramine results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human diquat increases expression EXP 6480464 Diquat results in increased expression of SLC7A11 mRNA CTD PMID:21172416 SLC7A11 Human disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of SLC7A11 mRNA CTD PMID:24383545 SLC7A11 Human diuron decreases expression EXP 6480464 Diuron results in decreased expression of SLC7A11 mRNA CTD PMID:35967413 SLC7A11 Human doramapimod increases expression ISO Slc7a11 (Mus musculus) 6480464 doramapimod results in increased expression of SLC7A11 mRNA CTD PMID:21328587 SLC7A11 Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SLC7A11 Human doxorubicin affects response to substance EXP 6480464 SLC7A11 protein affects the susceptibility to Doxorubicin CTD PMID:31226288 SLC7A11 Human doxorubicin decreases expression ISO Slc7a11 (Mus musculus) 6480464 Doxorubicin results in decreased expression of SLC7A11 mRNA and Doxorubicin results in decreased expression of SLC7A11 protein CTD PMID:35667395 SLC7A11 Human doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of SLC7A11 mRNA CTD PMID:29803840 SLC7A11 Human elemental selenium increases import EXP 6480464 SLC7A11 mRNA results in increased import of Selenium CTD PMID:28070112 SLC7A11 Human elesclomol multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC7A11 mRNA] CTD PMID:18723479 SLC7A11 Human elesclomol increases expression EXP 6480464 elesclomol results in increased expression of SLC7A11 mRNA CTD PMID:18723479 SLC7A11 Human endosulfan multiple interactions EXP 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of SLC7A11 mRNA CTD PMID:26159488 SLC7A11 Human endosulfan increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Endosulfan results in increased expression of SLC7A11 mRNA CTD PMID:29391264 SLC7A11 Human enniatin increases expression EXP 6480464 enniatins results in increased expression of SLC7A11 mRNA CTD PMID:30227181 more ... SLC7A11 Human entacapone decreases expression EXP 6480464 entacapone results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human Enterolactone decreases expression EXP 6480464 2 and 3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of SLC7A11 mRNA CTD PMID:19167446 SLC7A11 Human Enterolactone multiple interactions EXP 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SLC7A11 mRNA CTD PMID:19167446 SLC7A11 Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human entinostat increases expression EXP 6480464 entinostat results in increased expression of SLC7A11 mRNA CTD PMID:26272509 SLC7A11 Human epichlorohydrin increases expression EXP 6480464 Epichlorohydrin results in increased expression of SLC7A11 mRNA CTD PMID:24211530 SLC7A11 Human erastin multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 NFE2L2 protein promotes the reaction [erastin results in increased expression of SLC7A11 mRNA] CTD PMID:32937103 SLC7A11 Human erastin decreases expression ISO Slc7a11 (Mus musculus) 6480464 erastin results in decreased expression of SLC7A11 protein CTD PMID:37075931 SLC7A11 Human erastin multiple interactions ISO Slc7a11 (Mus musculus) 6480464 erastin promotes the reaction [Silicon Dioxide results in decreased expression of SLC7A11 protein] CTD PMID:37075931 SLC7A11 Human erastin multiple interactions EXP 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[indol-3-yl pyruvic acid co-treated with erastin] results in increased expression of SLC7A11 protein] more ... CTD PMID:34785303 and PMID:38641223 SLC7A11 Human erastin decreases expression EXP 6480464 erastin results in decreased expression of SLC7A11 protein CTD PMID:34785303 SLC7A11 Human erastin increases expression ISO Slc7a11 (Mus musculus) 6480464 erastin results in increased expression of SLC7A11 mRNA CTD PMID:38641223 SLC7A11 Human erastin increases expression EXP 6480464 erastin results in increased expression of SLC7A11 mRNA and erastin results in increased expression of SLC7A11 protein CTD PMID:38641223 SLC7A11 Human erastin increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 erastin results in increased expression of SLC7A11 mRNA CTD PMID:32937103 SLC7A11 Human eriodictyol decreases expression EXP 6480464 eriodictyol results in decreased expression of SLC7A11 protein CTD PMID:37020356 SLC7A11 Human estriol increases expression EXP 6480464 Estriol results in increased expression of SLC7A11 mRNA CTD PMID:15159206 SLC7A11 Human estrone increases expression EXP 6480464 Estrone results in increased expression of SLC7A11 mRNA CTD PMID:15159206 SLC7A11 Human ethambutol increases expression EXP 6480464 Ethambutol results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human ethambutol multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:36878459 SLC7A11 Human ethanol increases expression ISO Slc7a11 (Mus musculus) 6480464 Ethanol results in increased expression of SLC7A11 mRNA CTD PMID:30319688 SLC7A11 Human ethanol decreases expression ISO Slc7a11 (Mus musculus) 6480464 Ethanol results in decreased expression of SLC7A11 protein CTD PMID:33017621 SLC7A11 Human ethanol multiple interactions EXP 6480464 [CYP2E1 protein affects the susceptibility to Ethanol] which affects the expression of SLC7A11 protein and FXN protein affects the reaction [[CYP2E1 protein affects the susceptibility to Ethanol] which affects the expression of SLC7A11 protein] CTD PMID:33017621 SLC7A11 Human ethanol increases expression EXP 6480464 Ethanol results in increased expression of SLC7A11 mRNA CTD PMID:37149095 SLC7A11 Human Ethyl acrylate decreases expression EXP 6480464 ethyl acrylate results in decreased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human ethyl methanesulfonate increases expression EXP 6480464 Ethyl Methanesulfonate results in increased expression of SLC7A11 mRNA CTD PMID:23649840 SLC7A11 Human ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of SLC7A11 mRNA CTD PMID:20359517 SLC7A11 Human etoposide affects response to substance EXP 6480464 SLC7A11 protein affects the susceptibility to Etoposide CTD PMID:31226288 SLC7A11 Human eugenol increases expression EXP 6480464 Eugenol results in increased expression of SLC7A11 mRNA CTD PMID:26198647 and PMID:30806763 SLC7A11 Human farnesol increases expression EXP 6480464 Farnesol results in increased expression of SLC7A11 mRNA CTD PMID:30806763 SLC7A11 Human ferrostatin-1 decreases expression ISO Slc7a11 (Mus musculus) 6480464 ferrostatin-1 results in decreased expression of SLC7A11 protein CTD PMID:37075931 SLC7A11 Human ferrostatin-1 multiple interactions ISO Slc7a11 (Mus musculus) 6480464 ferrostatin-1 inhibits the reaction [Benzene results in decreased expression of SLC7A11 mRNA] more ... CTD PMID:34302894 more ... SLC7A11 Human ferrostatin-1 multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 ferrostatin-1 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SLC7A11 protein] and ferrostatin-1 inhibits the reaction [IL1B protein results in decreased expression of SLC7A11 protein] CTD PMID:33737050 and PMID:36084724 SLC7A11 Human ferrostatin-1 multiple interactions EXP 6480464 ferrostatin-1 affects the reaction [7 more ... CTD PMID:36450496 more ... SLC7A11 Human Fexofenadine hydrochloride decreases expression EXP 6480464 fexofenadine results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human fludrocortisone decreases expression EXP 6480464 Fludrocortisone results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human fluoranthene multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA and SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA] CTD PMID:28329830 SLC7A11 Human fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of SLC7A11 mRNA CTD PMID:24356939 SLC7A11 Human flutamide increases expression EXP 6480464 Flutamide results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human folic acid multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC7A11 mRNA CTD PMID:20938992 SLC7A11 Human folpet increases expression ISO Slc7a11 (Mus musculus) 6480464 folpet results in increased expression of SLC7A11 mRNA CTD PMID:31558096 SLC7A11 Human formaldehyde increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Formaldehyde results in increased expression of SLC7A11 mRNA CTD PMID:20884683 SLC7A11 Human formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of SLC7A11 mRNA CTD PMID:23649840 SLC7A11 Human FR900359 decreases phosphorylation EXP 6480464 FR900359 results in decreased phosphorylation of SLC7A11 protein CTD PMID:37730182 SLC7A11 Human gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of SLC7A11 mRNA CTD PMID:24356939 and PMID:26198647 SLC7A11 Human gedunin increases expression EXP 6480464 gedunin results in increased expression of SLC7A11 mRNA CTD PMID:17010675 SLC7A11 Human genistein decreases expression EXP 6480464 Genistein results in decreased expression of SLC7A11 mRNA CTD PMID:16474171 SLC7A11 Human genistein decreases expression ISO Slc7a11 (Mus musculus) 6480464 Genistein results in decreased expression of SLC7A11 mRNA CTD PMID:32186404 SLC7A11 Human gentamycin increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Gentamicins results in increased expression of SLC7A11 mRNA CTD PMID:33387578 SLC7A11 Human glucose multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:36806343 SLC7A11 Human glutathione increases abundance ISO Slc7a11 (Mus musculus) 6480464 SLC7A11 results in increased abundance of Glutathione CTD PMID:19015640 SLC7A11 Human glutathione multiple interactions EXP 6480464 [[[Bilirubin results in increased activity of [SLC7A11 protein co-treated with SLC3A2 protein]] which results in increased uptake of Cystine] which results in increased abundance of Glutathione] which results in decreased susceptibility to Hydrogen Peroxide more ... CTD PMID:22216172 and PMID:35234341 SLC7A11 Human glutathione multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased abundance of Glutathione] which results in increased abundance of Reactive Oxygen Species more ... CTD PMID:19015640 and PMID:23085521 SLC7A11 Human glycidol increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 glycidol results in increased expression of SLC7A11 mRNA CTD PMID:24915197 SLC7A11 Human hexadecanoic acid multiple interactions ISO Slc7a11 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]] more ... CTD PMID:38174997 SLC7A11 Human hexadecanoic acid decreases expression ISO Slc7a11 (Mus musculus) 6480464 Palmitic Acid results in decreased expression of SLC7A11 protein CTD PMID:38174997 SLC7A11 Human hexamethylene diisocyanate increases expression EXP 6480464 1 and 6-hexamethylene diisocyanate results in increased expression of SLC7A11 mRNA CTD PMID:24211530 SLC7A11 Human Hirsuteine multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 hirsuteine promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA] CTD PMID:25551766 SLC7A11 Human hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of SLC7A11 mRNA CTD PMID:12414654 SLC7A11 Human hydrogen peroxide affects expression EXP 6480464 Hydrogen Peroxide affects the expression of SLC7A11 mRNA CTD PMID:23410634 SLC7A11 Human hydrogen peroxide multiple interactions EXP 6480464 [[[Bilirubin results in increased activity of [SLC7A11 protein co-treated with SLC3A2 protein]] which results in increased uptake of Cystine] which results in increased abundance of Glutathione] which results in decreased susceptibility to Hydrogen Peroxide CTD PMID:22216172 SLC7A11 Human hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of SLC7A11 mRNA CTD PMID:18951874 SLC7A11 Human hydrogen sulfide multiple interactions EXP 6480464 [sodium bisulfide results in increased abundance of Hydrogen Sulfide] inhibits the reaction [beryllium sulfate results in decreased expression of SLC7A11 mRNA] CTD PMID:36843388 SLC7A11 Human hydroquinone increases expression EXP 6480464 hydroquinone results in increased expression of SLC7A11 mRNA CTD PMID:31256213 SLC7A11 Human hypochlorous acid increases expression ISO Slc7a11 (Mus musculus) 6480464 Hypochlorous Acid results in increased expression of SLC7A11 mRNA CTD PMID:19376150 SLC7A11 Human ibuprofen increases expression EXP 6480464 Ibuprofen results in increased expression of SLC7A11 mRNA CTD PMID:25596134 SLC7A11 Human Indeno[1,2,3-cd]pyrene increases expression EXP 6480464 indeno(1 more ... CTD PMID:32251684 SLC7A11 Human indoline multiple interactions EXP 6480464 [Thiazoles binds to indoline] promotes the reaction [1 and 3-dichloro-2-propanol results in decreased expression of SLC7A11 protein] CTD PMID:35870111 SLC7A11 Human indometacin increases expression EXP 6480464 Indomethacin results in increased expression of SLC7A11 mRNA CTD PMID:17401462 SLC7A11 Human indometacin increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Indomethacin results in increased expression of SLC7A11 mRNA CTD PMID:36868495 SLC7A11 Human inulin multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A11 mRNA CTD PMID:36331819 SLC7A11 Human isoniazide multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:36878459 SLC7A11 Human isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human KN-93 multiple interactions ISO Slc7a11 (Mus musculus) 6480464 KN 93 inhibits the reaction [Silicon Dioxide results in decreased expression of SLC7A11 protein] CTD PMID:37075931 SLC7A11 Human L-ascorbic acid increases expression EXP 6480464 Ascorbic Acid results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human L-cystine multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [SLC3A2 protein co-treated with SLC7A11 protein] results in increased uptake of Cystine and Sulfasalazine inhibits the reaction [[SLC3A2 protein co-treated with SLC7A11 protein] results in increased uptake of Cystine] CTD PMID:19576933 SLC7A11 Human L-cystine multiple interactions EXP 6480464 [[[Bilirubin results in increased activity of [SLC7A11 protein co-treated with SLC3A2 protein]] which results in increased uptake of Cystine] which results in increased abundance of Glutathione] which results in decreased susceptibility to Hydrogen Peroxide more ... CTD PMID:22216172 SLC7A11 Human L-glutamic acid multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 geissoschizine methylether promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA] more ... CTD PMID:25551766 SLC7A11 Human L-glutamic acid increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Glutamic Acid results in increased expression of SLC7A11 mRNA CTD PMID:25551766 SLC7A11 Human L-methionine multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC7A11 mRNA CTD PMID:20938992 SLC7A11 Human lead diacetate increases expression ISO Slc7a11 (Mus musculus) 6480464 lead acetate results in increased expression of SLC7A11 mRNA CTD PMID:25270620 SLC7A11 Human lead diacetate multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 mRNA and [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 protein CTD PMID:36642386 SLC7A11 Human lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC7A11 mRNA CTD PMID:22839698 more ... SLC7A11 Human lead(0) multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 mRNA and [lead acetate results in increased abundance of Lead] which results in decreased expression of SLC7A11 protein CTD PMID:36642386 SLC7A11 Human lead(0) increases expression EXP 6480464 Lead results in increased expression of SLC7A11 mRNA CTD PMID:37386098 SLC7A11 Human leflunomide increases expression EXP 6480464 leflunomide results in increased expression of SLC7A11 mRNA CTD PMID:28988120 SLC7A11 Human levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human lipoic acid multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 Thioctic Acid inhibits the reaction [methylmercuric chloride results in decreased expression of SLC7A11 protein] and Thioctic Acid inhibits the reaction [methylmercuric chloride results in increased expression of SLC7A11 mRNA] CTD PMID:32061141 SLC7A11 Human lipopolysaccharide multiple interactions ISO Slc7a11 (Mus musculus) 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of SLC7A11 mRNA] CTD PMID:25890327 SLC7A11 Human lipopolysaccharide multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:35811015 SLC7A11 Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of SLC7A11 mRNA CTD PMID:35811015 SLC7A11 Human lipopolysaccharide increases expression ISO Slc7a11 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of SLC7A11 mRNA CTD PMID:25890327 SLC7A11 Human lumiracoxib increases expression EXP 6480464 lumiracoxib results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human LY294002 multiple interactions ISO Slc7a11 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [ADORA2B protein affects the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein]] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Palmitic Acid results in decreased expression of SLC7A11 protein] CTD PMID:38174997 SLC7A11 Human malonaldehyde multiple interactions EXP 6480464 [[BGN mRNA alternative form binds to OTUB1 protein] which binds to and results in decreased ubiquitination of and results in increased stability of SLC7A11 protein] which results in decreased abundance of Malondialdehyde CTD PMID:35234341 SLC7A11 Human manganese(II) chloride increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 manganese chloride results in increased expression of SLC7A11 mRNA CTD PMID:28801915 SLC7A11 Human mebendazole increases expression EXP 6480464 Mebendazole results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human MeIQx increases expression EXP 6480464 2-amino-3 more ... CTD PMID:20816883 SLC7A11 Human menadione increases expression EXP 6480464 Vitamin K 3 results in increased expression of SLC7A11 mRNA CTD PMID:12414654 and PMID:23410634 SLC7A11 Human mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of SLC7A11 mRNA CTD PMID:26272509 SLC7A11 Human mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of SLC7A11 mRNA CTD PMID:38568856 SLC7A11 Human metformin increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Metformin results in increased expression of SLC7A11 mRNA CTD PMID:25596134 SLC7A11 Human methamphetamine increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Methamphetamine results in increased expression of SLC7A11 mRNA CTD PMID:28619521 SLC7A11 Human methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 SLC7A11 Human methyl methacrylate increases expression ISO Slc7a11 (Mus musculus) 6480464 Methylmethacrylate results in increased expression of SLC7A11 mRNA CTD PMID:16916219 SLC7A11 Human methylisothiazolinone increases expression EXP 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of SLC7A11 mRNA CTD PMID:30806763 SLC7A11 Human methylmercury chloride multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [methylmercuric chloride affects the localization of NFE2L2 protein] which results in increased expression of SLC7A11 mRNA more ... CTD PMID:20421342 and PMID:32061141 SLC7A11 Human methylmercury chloride increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 methylmercuric chloride results in increased expression of SLC7A11 mRNA CTD PMID:32061141 SLC7A11 Human methylmercury chloride decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 methylmercuric chloride results in decreased expression of SLC7A11 protein CTD PMID:32061141 SLC7A11 Human methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of SLC7A11 mRNA CTD PMID:23179753 more ... SLC7A11 Human methylmercury chloride affects response to substance EXP 6480464 SLC7A11 gene SNP affects the susceptibility to methylmercuric chloride CTD PMID:25622337 SLC7A11 Human microcystin-LR increases expression ISO Slc7a11 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of SLC7A11 mRNA CTD PMID:17654400 SLC7A11 Human mitomycin C decreases expression EXP 6480464 Mitomycin results in decreased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 mRNA CTD PMID:24356939 and PMID:36695872 SLC7A11 Human mono(2-ethylhexyl) phthalate multiple interactions EXP 6480464 RSL3 compound promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SLC7A11 protein] CTD PMID:36438553 SLC7A11 Human mono(2-ethylhexyl) phthalate multiple interactions ISO Slc7a11 (Mus musculus) 6480464 ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein] and HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein] CTD PMID:34863575 SLC7A11 Human mono(2-ethylhexyl) phthalate increases expression ISO Slc7a11 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 mRNA and mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein CTD PMID:34863575 SLC7A11 Human mono(2-ethylhexyl) phthalate decreases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in decreased expression of SLC7A11 protein CTD PMID:36438553 SLC7A11 Human motexafin gadolinium multiple interactions EXP 6480464 [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A11 mRNA CTD PMID:16357179 SLC7A11 Human motexafin gadolinium increases expression EXP 6480464 motexafin gadolinium results in increased expression of SLC7A11 mRNA CTD PMID:16357179 SLC7A11 Human mycophenolic acid decreases expression EXP 6480464 Mycophenolic Acid results in decreased expression of SLC7A11 mRNA CTD PMID:24356939 SLC7A11 Human N-acetyl-L-cysteine multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 Acetylcysteine inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] CTD PMID:19717140 SLC7A11 Human N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [elesclomol results in increased expression of SLC7A11 mRNA] CTD PMID:18723479 SLC7A11 Human N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal increases expression ISO Slc7a11 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of SLC7A11 mRNA CTD PMID:25566086 SLC7A11 Human N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC7A11 mRNA CTD PMID:24810058 and PMID:32870474 SLC7A11 Human N-methyl-4-phenylpyridinium multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 ferrostatin-1 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SLC7A11 protein] and pifithrin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SLC7A11 protein] CTD PMID:33737050 SLC7A11 Human N-methyl-4-phenylpyridinium decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC7A11 protein CTD PMID:33737050 SLC7A11 Human N-methyl-4-phenylpyridinium increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC7A11 mRNA CTD PMID:28801915 SLC7A11 Human N-methyl-4-phenylpyridinium increases methylation ISO Slc7a11 (Rattus norvegicus) 6480464 1-Methyl-4-phenylpyridinium results in increased methylation of SLC7A11 gene CTD PMID:28801915 SLC7A11 Human N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human N-Nitrosopyrrolidine increases expression EXP 6480464 N-Nitrosopyrrolidine results in increased expression of SLC7A11 mRNA CTD PMID:32234424 SLC7A11 Human naphthalene increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 naphthalene analog results in increased expression of SLC7A11 mRNA CTD PMID:24976557 SLC7A11 Human naphthalene-1,2-diol increases expression EXP 6480464 1 more ... CTD PMID:25807370 SLC7A11 Human nevirapine increases expression EXP 6480464 Nevirapine results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of SLC7A11 mRNA CTD PMID:24768652 and PMID:25583101 SLC7A11 Human nickel dichloride affects expression ISO Slc7a11 (Rattus norvegicus) 6480464 nickel chloride affects the expression of SLC7A11 mRNA CTD PMID:22110744 SLC7A11 Human nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of SLC7A11 mRNA CTD PMID:17312168 SLC7A11 Human nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of SLC7A11 mRNA CTD PMID:22714537 SLC7A11 Human nitrofen decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 nitrofen results in decreased expression of SLC7A11 mRNA CTD PMID:33484710 SLC7A11 Human Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of SLC7A11 mRNA CTD PMID:15159206 SLC7A11 Human O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of SLC7A11 mRNA CTD PMID:32234424 SLC7A11 Human o-xylene increases expression EXP 6480464 2-xylene results in increased expression of SLC7A11 mRNA CTD PMID:20359517 SLC7A11 Human ochratoxin A affects expression EXP 6480464 ochratoxin A affects the expression of SLC7A11 mRNA CTD PMID:23824090 SLC7A11 Human olanzapine decreases expression ISO Slc7a11 (Mus musculus) 6480464 Olanzapine results in decreased expression of SLC7A11 mRNA CTD PMID:37005277 SLC7A11 Human oseltamivir decreases expression EXP 6480464 Oseltamivir results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human oxybenzone affects expression ISO Slc7a11 (Rattus norvegicus) 6480464 oxybenzone affects the expression of SLC7A11 protein CTD PMID:31368502 SLC7A11 Human ozone increases expression ISO Slc7a11 (Mus musculus) 6480464 Ozone results in increased expression of SLC7A11 mRNA CTD PMID:17095637 SLC7A11 Human ozone multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of SLC7A11 mRNA CTD PMID:27106289 SLC7A11 Human ozone multiple interactions EXP 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:32699268 SLC7A11 Human ozone increases expression EXP 6480464 Ozone results in increased expression of SLC7A11 mRNA CTD PMID:28652203 SLC7A11 Human p-anisidine increases expression EXP 6480464 4-anisidine results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human p-chloromercuribenzoic acid increases expression EXP 6480464 p-Chloromercuribenzoic Acid results in increased expression of SLC7A11 mRNA CTD PMID:26272509 SLC7A11 Human p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human panobinostat increases expression EXP 6480464 panobinostat results in increased expression of SLC7A11 mRNA CTD PMID:26272509 SLC7A11 Human para-Cresidine decreases expression EXP 6480464 cresidine results in decreased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human paracetamol affects expression ISO Slc7a11 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC7A11 mRNA CTD PMID:17562736 SLC7A11 Human paracetamol increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Acetaminophen results in increased expression of SLC7A11 mRNA CTD PMID:30723492 more ... SLC7A11 Human paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of SLC7A11 mRNA CTD PMID:25458485 SLC7A11 Human paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC7A11 mRNA CTD PMID:21420995 and PMID:29067470 SLC7A11 Human paraquat multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 mRNA more ... CTD PMID:24530478 and PMID:37507096 SLC7A11 Human paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of SLC7A11 protein CTD PMID:37507096 SLC7A11 Human paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC7A11 mRNA CTD PMID:34097952 SLC7A11 Human paraquat increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Paraquat results in increased expression of SLC7A11 mRNA CTD PMID:32680482 SLC7A11 Human paraquat increases expression ISO Slc7a11 (Mus musculus) 6480464 Paraquat results in increased expression of SLC7A11 mRNA CTD PMID:23085521 SLC7A11 Human paraquat multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [SLC7A11 gene mutant form results in increased susceptibility to Paraquat] which results in decreased abundance of Glutathione CTD PMID:23085521 SLC7A11 Human paraquat increases response to substance ISO Slc7a11 (Mus musculus) 6480464 SLC7A11 gene mutant form results in increased susceptibility to Paraquat CTD PMID:23085521 SLC7A11 Human patulin increases expression EXP 6480464 Patulin results in increased expression of SLC7A11 protein CTD PMID:35772596 SLC7A11 Human patulin increases expression ISO Slc7a11 (Mus musculus) 6480464 Patulin results in increased expression of SLC7A11 protein CTD PMID:35772596 SLC7A11 Human patulin multiple interactions EXP 6480464 Patulin promotes the reaction [BECN1 protein modified form binds to SLC7A11 protein] CTD PMID:35772596 SLC7A11 Human penbutolol increases expression EXP 6480464 Penbutolol results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human perfluorononanoic acid increases expression EXP 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC7A11 mRNA CTD PMID:32588087 SLC7A11 Human perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of SLC7A11 mRNA CTD PMID:32588087 and PMID:36864359 SLC7A11 Human perfluorooctane-1-sulfonic acid multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC7A11 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC7A11 mRNA CTD PMID:36331819 SLC7A11 Human perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SLC7A11 mRNA CTD PMID:32588087 more ... SLC7A11 Human phenobarbital multiple interactions ISO Slc7a11 (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC7A11 mRNA] CTD PMID:19482888 SLC7A11 Human phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of SLC7A11 mRNA CTD PMID:19084549 SLC7A11 Human phenobarbital increases expression ISO Slc7a11 (Mus musculus) 6480464 Phenobarbital results in increased expression of SLC7A11 mRNA CTD PMID:19482888 SLC7A11 Human phenol increases expression EXP 6480464 Phenol results in increased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of SLC7A11 mRNA CTD PMID:26272509 SLC7A11 Human phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human phorbol 13-acetate 12-myristate increases expression ISO Slc7a11 (Mus musculus) 6480464 Tetradecanoylphorbol Acetate results in increased expression of SLC7A11 mRNA CTD PMID:17200146 SLC7A11 Human phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of SLC7A11 mRNA CTD PMID:17200146 and PMID:26198647 SLC7A11 Human pifithrin-? multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 pifithrin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of SLC7A11 protein] CTD PMID:33737050 SLC7A11 Human pinostrobin increases expression EXP 6480464 pinostrobin results in increased expression of SLC7A11 mRNA CTD PMID:37777166 SLC7A11 Human pioglitazone increases expression EXP 6480464 Pioglitazone results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human piroxicam decreases expression EXP 6480464 Piroxicam results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 SLC7A11 Human polymyxin B2 multiple interactions EXP 6480464 baicalein inhibits the reaction [Polymyxin B results in decreased expression of SLC7A11 protein] more ... CTD PMID:37088170 and PMID:37354967 SLC7A11 Human polymyxin B2 decreases expression EXP 6480464 Polymyxin B results in decreased expression of SLC7A11 protein CTD PMID:37088170 and PMID:37354967 SLC7A11 Human potassium bromate increases expression EXP 6480464 potassium bromate results in increased expression of SLC7A11 mRNA CTD PMID:30559759 SLC7A11 Human potassium dichromate increases expression ISO Slc7a11 (Mus musculus) 6480464 Potassium Dichromate results in increased expression of SLC7A11 mRNA CTD PMID:23608068 SLC7A11 Human potassium dichromate decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Potassium Dichromate results in decreased expression of SLC7A11 protein CTD PMID:36416502 SLC7A11 Human prednisolone decreases expression EXP 6480464 Prednisolone results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 SLC7A11 Human prednisolone increases expression EXP 6480464 Prednisolone results in increased expression of SLC7A11 mRNA CTD PMID:24356939 SLC7A11 Human procyanidin B1 multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 procyanidin B1 promotes the reaction [Glutamic Acid results in increased expression of SLC7A11 mRNA] CTD PMID:25551766 SLC7A11 Human procyclidine increases expression EXP 6480464 Procyclidine results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human progesterone increases expression EXP 6480464 Progesterone results in increased expression of SLC7A11 mRNA CTD PMID:18037150 SLC7A11 Human propan-2-ol increases expression EXP 6480464 2-Propanol results in increased expression of SLC7A11 mRNA CTD PMID:37149095 SLC7A11 Human propofol decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Propofol results in decreased expression of SLC7A11 protein CTD PMID:28663055 SLC7A11 Human propofol multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Propofol results in decreased expression of SLC7A11 protein] CTD PMID:28663055 SLC7A11 Human prothioconazole increases expression EXP 6480464 prothioconazole results in increased expression of SLC7A11 mRNA CTD PMID:35048155 SLC7A11 Human protriptyline decreases expression EXP 6480464 Protriptyline results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human pyrazinecarboxamide multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:36878459 SLC7A11 Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of SLC7A11 mRNA CTD PMID:21632981 and PMID:26198647 SLC7A11 Human rac-1,2-dichloropropane increases expression ISO Slc7a11 (Mus musculus) 6480464 propylene dichloride results in increased expression of SLC7A11 mRNA CTD PMID:37326970 SLC7A11 Human rac-1,2-dichloropropane multiple interactions ISO Slc7a11 (Mus musculus) 6480464 NFE2L2 gene mutant form inhibits the reaction [propylene dichloride results in increased expression of SLC7A11 mRNA] CTD PMID:37326970 SLC7A11 Human raloxifene increases expression EXP 6480464 Raloxifene Hydrochloride results in increased expression of SLC7A11 mRNA CTD PMID:16497877 SLC7A11 Human reactive oxygen species multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in decreased abundance of Glutathione] which results in increased abundance of Reactive Oxygen Species and [SLC7A11 results in increased abundance of Glutathione] which results in decreased abundance of Reactive Oxygen Species CTD PMID:19015640 SLC7A11 Human resorcinol decreases expression EXP 6480464 resorcinol results in decreased expression of SLC7A11 mRNA CTD PMID:22623647 and PMID:26198647 SLC7A11 Human resveratrol increases expression EXP 6480464 Resveratrol results in increased expression of SLC7A11 mRNA CTD PMID:37419272 SLC7A11 Human resveratrol multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Resveratrol inhibits the reaction [Rotenone results in decreased expression of SLC7A11 protein] CTD PMID:34391968 SLC7A11 Human resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [deoxynivalenol results in decreased expression of SLC7A11 protein] CTD PMID:37419272 SLC7A11 Human rifampicin multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 [Isoniazid co-treated with Rifampin co-treated with Pyrazinamide co-treated with Ethambutol] results in decreased expression of SLC7A11 mRNA more ... CTD PMID:36878459 SLC7A11 Human rotenone decreases expression ISO Slc7a11 (Mus musculus) 6480464 Rotenone results in decreased expression of SLC7A11 protein CTD PMID:34391968 and PMID:35919817 SLC7A11 Human rotenone multiple interactions ISO Slc7a11 (Mus musculus) 6480464 Resveratrol inhibits the reaction [Rotenone results in decreased expression of SLC7A11 protein] CTD PMID:34391968 SLC7A11 Human S-(1,2-dichlorovinyl)-L-cysteine increases expression EXP 6480464 S-(1 and 2-dichlorovinyl)cysteine results in increased expression of SLC7A11 mRNA CTD PMID:33725128 more ... SLC7A11 Human S-(1,2-dichlorovinyl)-L-cysteine multiple interactions EXP 6480464 [S-(1 more ... CTD PMID:35811015 SLC7A11 Human SB 203580 multiple interactions ISO Slc7a11 (Mus musculus) 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A11 mRNA] CTD PMID:28329830 SLC7A11 Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 SLC7A11 Human selenium atom increases import EXP 6480464 SLC7A11 mRNA results in increased import of Selenium CTD PMID:28070112 SLC7A11 Human sevoflurane decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Sevoflurane results in decreased expression of SLC7A11 protein CTD PMID:37494465 SLC7A11 Human sevoflurane multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 TBX2 protein affects the reaction [Sevoflurane results in decreased expression of SLC7A11 protein] CTD PMID:37494465 SLC7A11 Human Shikonin multiple interactions EXP 6480464 ATF3 protein promotes the reaction [shikonin results in decreased expression of SLC7A11 protein] CTD PMID:37268198 SLC7A11 Human Shikonin decreases expression ISO Slc7a11 (Mus musculus) 6480464 shikonin results in decreased expression of SLC7A11 protein CTD PMID:37268198 SLC7A11 Human Shikonin decreases expression EXP 6480464 shikonin results in decreased expression of SLC7A11 protein CTD PMID:37268198 SLC7A11 Human silicon dioxide increases expression ISO Slc7a11 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of SLC7A11 mRNA CTD PMID:19073995 and PMID:29341224 SLC7A11 Human silicon dioxide multiple interactions ISO Slc7a11 (Mus musculus) 6480464 erastin promotes the reaction [Silicon Dioxide results in decreased expression of SLC7A11 protein] more ... CTD PMID:37075931 SLC7A11 Human silicon dioxide decreases expression ISO Slc7a11 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of SLC7A11 protein CTD PMID:37075931 SLC7A11 Human silver atom increases expression EXP 6480464 Silver results in increased expression of SLC7A11 mRNA CTD PMID:26014281 and PMID:28959546 SLC7A11 Human silver atom increases expression ISO Slc7a11 (Mus musculus) 6480464 Silver results in increased expression of SLC7A11 mRNA CTD PMID:27131904 SLC7A11 Human silver(0) increases expression EXP 6480464 Silver results in increased expression of SLC7A11 mRNA CTD PMID:26014281 and PMID:28959546 SLC7A11 Human silver(0) increases expression ISO Slc7a11 (Mus musculus) 6480464 Silver results in increased expression of SLC7A11 mRNA CTD PMID:27131904 SLC7A11 Human sinapic acid increases expression ISO Slc7a11 (Mus musculus) 6480464 sinapinic acid analog results in increased expression of SLC7A11 mRNA CTD PMID:36279966 SLC7A11 Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of SLC7A11 mRNA CTD PMID:20886546 more ... SLC7A11 Human sodium arsenite affects expression ISO Slc7a11 (Mus musculus) 6480464 sodium arsenite affects the expression of SLC7A11 protein CTD PMID:32194376 SLC7A11 Human sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of SLC7A11 mRNA CTD PMID:34032870 SLC7A11 Human sodium arsenite increases expression ISO Slc7a11 (Mus musculus) 6480464 sodium arsenite results in increased expression of SLC7A11 CTD PMID:29204679 SLC7A11 Human sodium arsenite affects methylation EXP 6480464 sodium arsenite affects the methylation of SLC7A11 gene CTD PMID:28589171 SLC7A11 Human sodium aurothiomalate decreases expression EXP 6480464 Gold Sodium Thiomalate results in decreased expression of SLC7A11 mRNA CTD PMID:19192274 SLC7A11 Human sodium dichromate affects expression ISO Slc7a11 (Rattus norvegicus) 6480464 sodium bichromate affects the expression of SLC7A11 mRNA CTD PMID:22110744 SLC7A11 Human sodium dodecyl sulfate increases expression EXP 6480464 Sodium Dodecyl Sulfate results in increased expression of SLC7A11 mRNA CTD PMID:30806763 SLC7A11 Human sodium fluoride decreases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Sodium Fluoride results in decreased expression of SLC7A11 mRNA CTD PMID:27257137 SLC7A11 Human sodium fluoride increases expression ISO Slc7a11 (Mus musculus) 6480464 Sodium Fluoride results in increased expression of SLC7A11 mRNA CTD PMID:37245782 SLC7A11 Human sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of SLC7A11 mRNA and Sodium Fluoride results in decreased expression of SLC7A11 protein CTD PMID:38342390 SLC7A11 Human sodium hypochlorite increases expression EXP 6480464 Sodium Hypochlorite results in increased expression of SLC7A11 mRNA CTD PMID:37149095 SLC7A11 Human solasodine decreases expression EXP 6480464 solasodine results in decreased expression of SLC7A11 protein CTD PMID:37121296 SLC7A11 Human sorafenib decreases expression EXP 6480464 Sorafenib results in decreased expression of SLC7A11 protein CTD PMID:36321791 SLC7A11 Human sorafenib multiple interactions EXP 6480464 SLC7A11 protein affects the reaction [SNHG1 protein results in decreased susceptibility to Sorafenib] and Sorafenib promotes the reaction [arsenic disulfide results in decreased expression of SLC7A11 protein] CTD PMID:36321791 and PMID:37927237 SLC7A11 Human succimer multiple interactions ISO Slc7a11 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC7A11 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC7A11 mRNA CTD PMID:21641980 and PMID:26378955 SLC7A11 Human succimer multiple interactions EXP 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC7A11 mRNA CTD PMID:26378955 SLC7A11 Human sulfasalazine decreases activity EXP 6480464 Sulfasalazine results in decreased activity of SLC7A11 protein CTD PMID:20007406 SLC7A11 Human sulfasalazine decreases activity ISO Slc7a11 (Mus musculus) 6480464 Sulfasalazine results in decreased activity of SLC7A11 protein CTD PMID:19015640 SLC7A11 Human sulfasalazine multiple interactions ISO Slc7a11 (Mus musculus) 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[Sulfasalazine results in decreased activity of SLC7A11 protein] which results in increased expression of CAV1 mRNA] more ... CTD PMID:19015640 and PMID:19576933 SLC7A11 Human sulforaphane increases expression EXP 6480464 sulforaphane results in increased expression of SLC7A11 mRNA CTD PMID:31838189 and PMID:34767876 SLC7A11 Human sunitinib increases expression EXP 6480464 Sunitinib results in increased expression of SLC7A11 mRNA CTD PMID:31533062 SLC7A11 Human temozolomide increases expression EXP 6480464 Temozolomide results in increased expression of SLC7A11 mRNA CTD PMID:31758290 SLC7A11 Human tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of SLC7A11 mRNA CTD PMID:12414654 and PMID:23410634 SLC7A11 Human tetrachloromethane increases expression ISO Slc7a11 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC7A11 mRNA CTD PMID:27339419 and PMID:31919559 SLC7A11 Human tetrachloromethane increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Carbon Tetrachloride results in increased expression of SLC7A11 mRNA CTD PMID:30723492 and PMID:31150632 SLC7A11 Human tetrachloromethane multiple interactions ISO Slc7a11 (Rattus norvegicus) 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC7A11 mRNA] CTD PMID:31150632 SLC7A11 Human tetraphene decreases expression ISO Slc7a11 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of SLC7A11 mRNA CTD PMID:26377693 SLC7A11 Human tetrathiomolybdate(2-) increases expression EXP 6480464 tetrathiomolybdate analog results in increased expression of SLC7A11 mRNA CTD PMID:19323979 SLC7A11 Human thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of SLC7A11 mRNA CTD PMID:29453283 SLC7A11 Human thiamethoxam increases expression ISO Slc7a11 (Mus musculus) 6480464 Thiamethoxam results in increased expression of SLC7A11 mRNA CTD PMID:33533595 SLC7A11 Human thiazoles multiple interactions EXP 6480464 [Thiazoles binds to indoline] promotes the reaction [1 and 3-dichloro-2-propanol results in decreased expression of SLC7A11 protein] CTD PMID:35870111 SLC7A11 Human thioacetamide increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of SLC7A11 mRNA CTD PMID:34492290 SLC7A11 Human thiram increases expression EXP 6480464 Thiram results in increased expression of SLC7A11 mRNA CTD PMID:24211530 and PMID:38568856 SLC7A11 Human tienilic acid increases expression EXP 6480464 Ticrynafen results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human titanium dioxide decreases expression ISO Slc7a11 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SLC7A11 mRNA CTD PMID:29264374 SLC7A11 Human titanium dioxide increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 titanium dioxide results in increased expression of SLC7A11 mRNA CTD PMID:30012374 SLC7A11 Human tolcapone decreases expression EXP 6480464 Tolcapone results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human toluene increases expression EXP 6480464 Toluene results in increased expression of SLC7A11 mRNA CTD PMID:20359517 and PMID:28245982 SLC7A11 Human trazodone increases expression EXP 6480464 Trazodone results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human triacsin C increases expression EXP 6480464 triacsin C results in increased expression of SLC7A11 mRNA CTD PMID:16704987 SLC7A11 Human Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of SLC7A11 mRNA CTD PMID:26198647 SLC7A11 Human trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC7A11 mRNA CTD PMID:20359517 SLC7A11 Human trichloroethene increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 Trichloroethylene results in increased expression of SLC7A11 mRNA CTD PMID:33387578 SLC7A11 Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of SLC7A11 mRNA CTD PMID:24935251 and PMID:26272509 SLC7A11 Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human Trihexyphenidyl increases expression EXP 6480464 Trihexyphenidyl results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human trimellitic anhydride increases expression ISO Slc7a11 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of SLC7A11 mRNA CTD PMID:19042947 SLC7A11 Human triphenyl phosphate increases expression ISO Slc7a11 (Rattus norvegicus) 6480464 triphenyl phosphate results in increased expression of SLC7A11 mRNA CTD PMID:30589522 SLC7A11 Human triptonide decreases expression ISO Slc7a11 (Mus musculus) 6480464 triptonide results in decreased expression of SLC7A11 mRNA CTD PMID:33045310 SLC7A11 Human tris(2-butoxyethyl) phosphate affects expression EXP 6480464 tris(2-butoxyethyl) phosphate affects the expression of SLC7A11 mRNA CTD PMID:29024780 SLC7A11 Human troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human trovafloxacin decreases expression ISO Slc7a11 (Mus musculus) 6480464 trovafloxacin results in decreased expression of SLC7A11 mRNA CTD PMID:35537566 SLC7A11 Human tunicamycin increases expression ISO Slc7a11 (Mus musculus) 6480464 Tunicamycin results in increased expression of SLC7A11 mRNA CTD PMID:17127020 SLC7A11 Human tunicamycin increases expression EXP 6480464 Tunicamycin results in increased expression of SLC7A11 mRNA CTD PMID:29453283 more ... SLC7A11 Human urethane increases expression EXP 6480464 Urethane results in increased expression of SLC7A11 mRNA CTD PMID:28818685 SLC7A11 Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of SLC7A11 mRNA CTD PMID:25979313 SLC7A11 Human valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human valproic acid affects splicing ISO Slc7a11 (Rattus norvegicus) 6480464 Valproic Acid affects the splicing of SLC7A11 mRNA CTD PMID:29427782 SLC7A11 Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of SLC7A11 mRNA CTD PMID:23179753 more ... SLC7A11 Human valproic acid decreases expression ISO Slc7a11 (Mus musculus) 6480464 Valproic Acid results in decreased expression of SLC7A11 mRNA CTD PMID:24896083 SLC7A11 Human Valtratum decreases expression EXP 6480464 valtrate results in decreased expression of SLC7A11 protein CTD PMID:36048842 SLC7A11 Human Valtratum multiple interactions EXP 6480464 SLC7A11 protein inhibits the reaction [valtrate results in decreased expression of GPX4 protein] CTD PMID:36048842 SLC7A11 Human vanillin increases expression EXP 6480464 vanillin results in increased expression of SLC7A11 mRNA CTD PMID:17178418 SLC7A11 Human vincristine increases expression EXP 6480464 Vincristine results in increased expression of SLC7A11 mRNA CTD PMID:23649840 SLC7A11 Human vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A11 mRNA CTD PMID:27188386 SLC7A11 Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of SLC7A11 mRNA CTD PMID:26272509 SLC7A11 Human zafirlukast decreases expression EXP 6480464 zafirlukast results in decreased expression of SLC7A11 mRNA CTD PMID:32816093 SLC7A11 Human zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of SLC7A11 mRNA CTD PMID:25424538 SLC7A11 Human zinc acetate multiple interactions EXP 6480464 [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A11 mRNA CTD PMID:16357179 SLC7A11 Human zinc acetate increases expression EXP 6480464 Zinc Acetate results in increased expression of SLC7A11 mRNA CTD PMID:16357179 SLC7A11 Human zinc atom multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC7A11 mRNA CTD PMID:18593933 SLC7A11 Human zinc(0) multiple interactions EXP 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC7A11 mRNA CTD PMID:18593933 SLC7A11 Human ziram increases expression EXP 6480464 Ziram results in increased expression of SLC7A11 mRNA CTD PMID:32870474
